Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Pfizer Inc | 48 |
| 2 | Bristol Myers Squibb Co | 47 |
| 3 | Abbott Laboratories | 24 |
| 4 | Selvita SA | 21 |
| 5 | Cormedix Inc | 20 |
| 6 | GSK PLC | 16 |
| 7 | Merck and Co Inc | 13 |
| 8 | Leland Stanford Junior University | 10 |
| 9 | Basilea Pharmaceutica AG | 7 |
| 10 | Enanta Pharmaceuticals Inc | 7 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | C07H | Sugars and derivatives | 236 |
| 2 | A61P | Therapeutic activity (drug indications) | 214 |
| 3 | A61K | Medicinal preparations | 97 |
| 4 | C12N | Microorganisms, enzymes | 85 |
| 5 | C07D | Heterocyclic compounds | 81 |
| 6 | C12P | Fermentation, enzyme processes | 77 |
| 7 | C07K | Peptides | 23 |
| 8 | Y02P | Climate change mitigation: production | 23 |
| 9 | C40B | 14 | |
| 10 | Y02A | Climate change adaptation | 11 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| Carbohydrate conjugates as delivery agents for oligonucleotides | 2012 | Alnylam Pharmaceuticals Inc | 515 |
| CARBOHYDRATE CONJUGATES AS DELIVERY AGENTS FOR OLIGONUCLEOTIDES | 2009 | Alnylam Pharmaceuticals Inc | 428 |
| MODIFIED iRNA AGENTS | 2012 | Alnylam Pharmaceuticals Inc | 207 |
| N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor | 1984 | Pfizer Inc | 242 |
| Erythromycins and process for their preparation | 2001 | 91 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Hung‐wen Liu | The University of Texas at Austin | 10 |
| 2 | Lishan Zhao | University of Minnesota | 4 |
| 3 | David H. Sherman | University of Michigan | 3 |
| 4 | Hazel M. Holden | University of Wisconsin–Madison | 3 |
| 5 | E. Sethe Burgie | University of Wisconsin–Madison | 3 |
| 6 | Giorgio Corti | National Research Council | 3 |
| 7 | Yeo Joon Yoon | Ewha Womans University Medical Center | 3 |
| 8 | Svetlana A. Borisova | The University of Texas at Austin | 3 |
| 9 | Silvio Bicciato | University of Modena and Reggio Emilia | 3 |
| 10 | Mark W. Ruszczycky | The University of Texas at Austin | 3 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| The Structural Basis for Substrate Anchoring, Active Site Selectivity, and Product Formation by P450 PikC from Streptomyces venezuelae | 2006 | 148 | Microbial Natural Products and Biosynthesis |
| Photodegradation of azithromycin in various aqueous systems under simulated and natural solar radiation: Kinetics and identification of photoproducts | 2011 | 124 | Pharmaceutical and Antibiotic Environmental Impacts |
| Construction of desosamine containing polyketide libraries using a glycosyltransferase with broad substrate specificity | 2001 | 86 | Microbial Natural Products and Biosynthesis |
| Stereoselective Synthesis of d -Desosamine and Related Glycals via Tungsten-Catalyzed Alkynol Cycloisomerization | 2004 | 73 | Carbohydrate Chemistry and Synthesis |
| Macrolide Therapy in Chronic Inflammatory Diseases | 2012 | 70 | Pneumonia and Respiratory Infections |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
Which organizations hold the most patents involving this compound?
What is the molecular composition of this compound?
Which academic researchers have published the most work related to this compound?
What are the primary research areas covered by patents for this compound?
What notable patent exists covering macrolide-related chemistry with this compound?